Morrison Foerster advised Amino Health, a comprehensive healthcare navigation platform that connects members to high-quality, in-network care with built-in cost transparency, in connection to its sale to Capital Rx, Inc., the enterprise health technology company. The acquisition of Amino Health will extend Capital Rx’s enterprise platform capabilities to nearly 60 million covered lives across the company’s portfolio.
The MoFo team advising Amino Health was led by New York M&A partner Scott Behar and San Francisco emerging companies + venture capital partner Michael Glaser.
